Perspective on dabigatran etexilate dosing: why not follow standard pharmacological principles?

Authors

  • Paul K. L. Chin,

    Corresponding author
    1. Department of Clinical Pharmacology, Christchurch Hospital, 2 Riccarton Avenue, Christchurch 8011, New Zealand
      Dr Paul K. L. Chin, Department of Clinical Pharmacology, Christchurch Hospital, 2 Riccarton Avenue, Christchurch 8011, New Zealand. Tel.: +64 3 364 640 extension 88354. Fax: +64 3 364 1003. E-mail: paulc@cdhb.health.nz
    Search for more papers by this author
  • Jane W. A. Vella-Brincat,

    1. Department of Clinical Pharmacology, Christchurch Hospital, 2 Riccarton Avenue, Christchurch 8011, New Zealand
    Search for more papers by this author
  • Murray L. Barclay,

    1. Department of Clinical Pharmacology, Christchurch Hospital, 2 Riccarton Avenue, Christchurch 8011, New Zealand
    Search for more papers by this author
  • Evan J. Begg

    1. Department of Clinical Pharmacology, Christchurch Hospital, 2 Riccarton Avenue, Christchurch 8011, New Zealand
    Search for more papers by this author

Dr Paul K. L. Chin, Department of Clinical Pharmacology, Christchurch Hospital, 2 Riccarton Avenue, Christchurch 8011, New Zealand. Tel.: +64 3 364 640 extension 88354. Fax: +64 3 364 1003. E-mail: paulc@cdhb.health.nz

Ancillary